Antipathogenic polymers
Antipathogenic polymers with N-alkylacrylamide units effectively inactivate SARS-CoV-2 and variants by binding and degrading viral RNA, addressing the inefficiencies of existing technologies in surface transmission.
JP2026520413APending Publication Date: 2026-06-23THE BOEING CO
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- THE BOEING CO
- Filing Date
- 2024-05-15
- Publication Date
- 2026-06-23
Smart Images
Figure 2026520413000001_ABST
Abstract
The present disclosure provides a method and a composition for disposing a polymer on a surface. The method includes depositing a polymer on the surface. The polymer includes a plurality of N-alkylacrylamide units. The compound has the following formula: TIFF2026520413000062.tif19170(where R 1 is C1-C 20 alkyl). The compound has the following formula: TIFF2026520413000063.tif28170(where R 2 , R 3 and R 4 are each independently hydrogen or C1-C 20 alkyl). The compound has the following formula: TIFF2026520413000064.tif60170(where Q is O or N, R ** is C1-C 20 alkyl, R 6 , R 7 and R 8 are independently C1-C6 alkyl or hydrogen, R 9 is, when present, C1-C 16 alkyl, C1-C6 alkylene, an azole, guanidine, an oligomer of guanidine such as diguanidine, a polysaccharide, a chromophore, and one or a combination of more than one of these, and q is an integer of 0 or 1). At least one q is 1.
Need to check novelty before this filing date? Find Prior Art